Verve Therapeutics Inc (VERV) - News Archive

Showing 2 of 22 results.

Verve Therapeutics Empowers Future of Cardiovascular Care with Public Offering and Gene Editing Advancements

Verve Therapeutics Announces Public Offering and Private Placement to Advance Cardiovascular Disease Gene Editing MedicinesBOSTON, Nov. 28, 2023 - Verve Therapeutics, Inc. (Nasdaq: VERV), a clinical-stage biotechnology...

Nov 28, 2023 Shares

Verve Therapeutics Inc: Pioneering Cardiovascular Therapies and Empowering Lives

In a recent development that has garnered significant attention within the healthcare and biotechnology sectors, Verve Therapeutics Inc has taken bold steps towards bolstering its position in the cardiovascular therapy...

Oct 31, 2023 Earnings announcement gene editing